Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022–2024: results from the CLEAR registry | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1How is ceftobiprole used in Canada: the CLEAR study final results2024 · 8 citations
2Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter StudyOriginal Research · 2018 · 127 citations
3Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosaRetrospective Study · 2017 · 143 citations
4Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015–2017) Pseudomonas aeruginosa isolates from a global surveillance programmeOriginal Research · 2019 · 33 citations
5Clinical Characteristics, Infection Profiles, and Hospital Outcomes of Intensive Care Unit Patients Undergoing Antimicrobial Therapy with Ceftolozane/Tazobactam: A Multicentric Retrospective AnalysisCohort Study · 2026
6Ceftolozane/Tazobactam for Complex and Resistant Infections: Systematic Reviews of Comparative Efficacy StudiesSystematic Review · 2026
7In vitro activity of ceftolozane/tazobactam against Gram-negative bacilli isolated from pediatric patients: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017–2021, China2024 · 1 citations
8Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015Original Research · 2017 · 82 citations
9Perspectives from Taiwan: managing comorbidities amongst the Taiwanese population treating HIV with antiretroviral therapyExpert Review of Anti-infective Therapy · 2026
10Engineering smart liposomes to combat antimicrobial resistance: from mechanistic design to clinical translationExpert Review of Anti-infective Therapy · 2026

More from Expert Review of Anti-infective Therapy

More from University of British Columbia